Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
BörsenkürzelELMD
Name des UnternehmensElectromed Inc
IPO-datumAug 13, 2010
CEOMr. James L. (Jim) Cunniff
Anzahl der mitarbeiter174
WertpapierartOrdinary Share
GeschäftsjahresendeAug 13
Addresse500 Sixth Avenue Nw
StadtNEW PRAGUE
BörseNYSE American Consolidated
LandUnited States of America
Postleitzahl56071
Telefon19527589299
Websitehttps://smartvest.com/
BörsenkürzelELMD
IPO-datumAug 13, 2010
CEOMr. James L. (Jim) Cunniff
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten